Here’s the last roundup of the latest coronavirus-related news in 2020.
Last week, the FDA granted emergency use authorization (EUA) to Moderna’s vaccine candidate for COVID-19 for use in individuals 18 years of age and older.
Officials with the FDA have affirmed that pharmacists administering the Pfizer/BioNTech COVID-19 vaccine can use leftover doses in vials containing multiple doses, which may boost the US supply by up to 40%, according to reporting by Politico.
Although US health care workers have started receiving the Pfizer-BioNTech COVID-19 vaccine, vaccines for children won’t be available for “months,” according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
The National Institutes of Health (NIH) has awarded 8 new research grants to help identify children who are at high risk of contracting multisystem inflammatory syndrome in children (MIS-C), a severe result of COVID-19 in some children.